{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T23:44:05Z","timestamp":1790639045678,"version":"4.1.0"},"reference-count":35,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,8,13]],"date-time":"2021-08-13T00:00:00Z","timestamp":1628812800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>Advanced Therapy Medicinal Products (ATMP) provide promising treatment options particularly for unmet clinical needs, such as progressive and chronic diseases where currently no satisfying treatment exists. Especially from the ATMP subclass of Tissue Engineered Products (TEPs), only a few have yet been translated from an academic setting to clinic and beyond. A reason for low numbers of TEPs in current clinical trials and one main key hurdle for TEPs is the cost and labor-intensive manufacturing process. Manual production steps require experienced personnel, are challenging to standardize and to scale up. Automated manufacturing has the potential to overcome these challenges, toward an increasing cost-effectiveness. One major obstacle for automation is the control and risk prevention of cross contaminations, especially when handling parallel production lines of different patient material. These critical steps necessitate validated effective and efficient cleaning procedures in an automated system. In this perspective, possible technologies, concepts and solutions to existing ATMP manufacturing hurdles are discussed on the example of a late clinical phase II trial TEP. In compliance to Good Manufacturing Practice (GMP) guidelines, we propose a dual arm robot based isolator approach. Our novel concept enables complete process automation for adherent cell culture, and the translation of all manual process steps with standard laboratory equipment. Moreover, we discuss novel solutions for automated cleaning, without the need for human intervention. Consequently, our automation concept offers the unique chance to scale up production while becoming more cost-effective, which will ultimately increase TEP availability to a broader number of patients.<\/jats:p>","DOI":"10.3389\/fmed.2021.712917","type":"journal-article","created":{"date-parts":[[2021,8,13]],"date-time":"2021-08-13T09:49:45Z","timestamp":1628848185000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":16,"title":["From Single Batch to Mass Production\u2013Automated Platform Design Concept for a Phase II Clinical Trial Tissue Engineered Cartilage Product"],"prefix":"10.3389","volume":"8","author":[{"given":"Sebastian","family":"Haeusner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Herbst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Bittorf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Schwarz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Henze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Mauermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jelena","family":"Ochs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Schmitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Blache","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anke","family":"Wixmerten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvie","family":"Miot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Pullig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,8,13]]},"reference":[{"key":"B1","article-title":"EUROPEAN MEDICINES AGENCY Reflection Paper on Classification of Advanced Therapy Medicinal Products, EMA\/CAT\/600280\/2010 rev.1","year":"2015"},{"key":"B2","unstructured":"Die forschenden Pharma Unternehmen2021"},{"key":"B3","unstructured":"Knee articular cartilage repair for athletes1721\n            HamblyK\n          16000659SportEx Med392009"},{"key":"B4","doi-asserted-by":"publisher","first-page":"3854","DOI":"10.1016\/j.arth.2017.07.021","article-title":"Patient Dissatisfaction following total knee arthroplasty: a systematic review of the literature","volume":"32","author":"Gunaratne","year":"2017","journal-title":"J Arthroplasty."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1016\/S0140-6736(17)30190-3","article-title":"Total joint arthroplasty in younger patients: heading for trouble?","volume":"389","author":"Schreurs","year":"2017","journal-title":"Lancet."},{"key":"B6","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.arth.2020.08.052","article-title":"Revision Total knee arthroplasty in young patients: higher early reoperation and rerevision","volume":"36","author":"Walker-Santiago","year":"2021","journal-title":"J Arthroplasty."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1055\/s-0040-1721053","article-title":"Management of large focal chondral and osteochondral defects in the knee","volume":"33","author":"Calcei","year":"2020","journal-title":"J Knee Surg."},{"key":"B8","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1177\/1947603520967065","article-title":"Comparison of autologous chondrocyte implantation and osteochondral allograft transplantation of the knee in a large insurance database: reoperation rate, complications, and cost analysis","volume":"11","author":"Sochacki","year":"2020","journal-title":"Cartilage"},{"key":"B9","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1007\/s43465-021-00355-z","article-title":"Managing chondral lesions: a literature review and evidence-based clinical guidelines","volume":"55","author":"Banerjee","year":"2021","journal-title":"Indian J Orthop."},{"key":"B10","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1177\/0363546520988069","article-title":"Five-year outcome of 1-stage cell-based cartilage repair using recycled autologous chondrons and allogenic mesenchymal stromal cells: a first-in-human clinical trial","volume":"49","author":"Saris","year":"2021","journal-title":"Am J Sports Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"643","DOI":"10.3390\/cells10030643","article-title":"Trends in articular cartilage tissue engineering: 3D mesenchymal stem cell sheets as candidates for engineered hyaline-like cartilage","volume":"10","author":"Thorp","year":"2021","journal-title":"Cells."},{"key":"B12","unstructured":"2021"},{"key":"B13","unstructured":"2018"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1016\/S0140-6736(16)31658-0","article-title":"Nasal chondrocyte-based engineered autologous cartilage tissue for repair of articular cartilage defects: an observational first-in-human trial","volume":"388","author":"Mumme","year":"2016","journal-title":"Lancet."},{"key":"B15","doi-asserted-by":"publisher","first-page":"615","DOI":"10.2217\/17460751.1.5.615","article-title":"Regenerative medicine bioprocessing: the need to learn from the experience of other fields","volume":"1","author":"Mason","year":"2006","journal-title":"Regen Med."},{"key":"B16","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.tibtech.2009.06.002","article-title":"Bioreactor-based roadmap for the translation of tissue engineering strategies into clinical products","volume":"27","author":"Martin","year":"2009","journal-title":"Trends Biotechnol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1089\/ten.tec.2010.0581","article-title":"Development of an operator-independent method for seeding tissue-engineered vascular grafts","volume":"17","author":"Udelsman","year":"2011","journal-title":"Tissue Eng Part C Methods."},{"key":"B18","doi-asserted-by":"publisher","first-page":"351","DOI":"10.2217\/rme-2016-0040","article-title":"Developing an automated robotic factory for novel stem cell therapy production","volume":"11","author":"Rafiq","year":"2016","journal-title":"Regen Med."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1007\/s10529-019-02732-z","article-title":"Automation in cell and gene therapy manufacturing: from past to future","volume":"41","author":"Moutsatsou","year":"2019","journal-title":"Biotechnol Lett."},{"key":"B20","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/978-1-61779-367-7_26","article-title":"Automated adherent human cell culture (mesenchymal stem cells)","volume":"806","author":"Thomas","year":"2012","journal-title":"Methods Mol Biol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1016\/j.jcyt.2016.05.009","article-title":"Automated manufacturing of chimeric antigen receptor T cells for adoptive immunotherapy using CliniMACS prodigy","volume":"18","author":"Mock","year":"2016","journal-title":"Cytotherapy."},{"key":"B22","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1089\/hum.2017.157","article-title":"Optimization of human NK cell manufacturing: fully automated separation, improved ex vivo expansion using IL-21 with autologous feeder cells, and generation of anti-CD123-CAR-expressing effector cells","volume":"28","author":"Kloss","year":"2017","journal-title":"Hum Gene Ther."},{"key":"B23","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.jcyt.2017.09.005","article-title":"Closed-system manufacturing of CD19 and dual-targeted CD20\/19 chimeric antigen receptor T cells using the CliniMACS Prodigy device at an academic medical center","volume":"20","author":"Zhu","year":"2018","journal-title":"Cytotherapy."},{"key":"B24","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1089\/hgtb.2019.039","article-title":"Development of automated separation, expansion, and quality control protocols for clinical-scale manufacturing of primary human NK cells and alpharetroviral chimeric antigen receptor engineering","volume":"30","author":"Oberschmidt","year":"2019","journal-title":"Hum Gene Ther Methods."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.3389\/fimmu.2020.01941","article-title":"Automated manufacture of autologous CD19 CAR-T cells for treatment of non-hodgkin lymphoma","volume":"11","author":"Jackson","year":"2020","journal-title":"Front Immunol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1038\/s41591-020-1081-3","article-title":"Bispecific anti-CD20, anti-CD19 CAR T cells for relapsed B cell malignancies: a phase 1 dose escalation and expansion trial","volume":"26","author":"Shah","year":"2020","journal-title":"Nat Med."},{"key":"B27","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.reth.2018.08.004","article-title":"A novel, flexible and automated manufacturing facility for cell-based health care products: tissue Factory","volume":"9","author":"Kikuchi","year":"2018","journal-title":"Regen Ther."},{"key":"B28","doi-asserted-by":"publisher","first-page":"5728","DOI":"10.3390\/ijms22115728","article-title":"Novel methods to mobilize, isolate, and expand mesenchymal stem cells","volume":"22","author":"Vieira","year":"2021","journal-title":"Int J Mol Sci."},{"key":"B29","unstructured":"EU Guidelines to Good Manufacturing Practice Medicinal Products for Human and Veterinary Use2010"},{"key":"B30","doi-asserted-by":"publisher","first-page":"240","DOI":"10.3390\/pr9020240","article-title":"Techno-economic analysis of automated iPSC production","volume":"9","author":"Nie\u00dfing","year":"2021","journal-title":"Processes"},{"key":"B31","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.joca.2009.08.009","article-title":"Evaluation of histological scoring systems for tissue-engineered, repaired and osteoarthritic cartilage","volume":"18","author":"Rutgers","year":"2010","journal-title":"Osteoarthritis Cartilage."},{"key":"B32","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.joca.2020.12.018","article-title":"Deep learning enables the automation of grading histological tissue engineered cartilage images for quality control standardization","volume":"29","author":"Power","year":"2021","journal-title":"Osteoarthritis Cartilage."},{"key":"B33","doi-asserted-by":"publisher","first-page":"112467","DOI":"10.1016\/j.bios.2020.112467","article-title":"Sensing tissue engineered cartilage quality with Raman spectroscopy and statistical learning for the development of advanced characterization assays","volume":"166","author":"Power","year":"2020","journal-title":"Biosens Bioelectron."},{"key":"B34","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.biosystemseng.2015.06.006","article-title":"Real-time characterisation of the harvesting process for adherent mesenchymal stem cell cultures based on on-line imaging and model-based monitoring","volume":"138","author":"Viazzi","year":"2015","journal-title":"Biosyst Eng."},{"key":"B35","doi-asserted-by":"publisher","first-page":"232fs16","DOI":"10.1126\/scitranslmed.3008558","article-title":"Manufacturing challenges in regenerative medicine","volume":"6","author":"Martin","year":"2014","journal-title":"Sci Transl Med."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2021.712917\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,13]],"date-time":"2021-08-13T09:49:47Z","timestamp":1628848187000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2021.712917\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,13]]},"references-count":35,"alternative-id":["10.3389\/fmed.2021.712917"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2021.712917","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,13]]},"article-number":"712917"}}